Kolkata, Nov 1:Life sciences firm Tarsons Products, which is expected to hit the capital market with an IPO size of Rs 1,000-1,200 crore this month, is likely to become the country’s first company in the manufacturing of PCR and cell culture products segment. Globally, the market for such laboratory products is estimated at Rs 24,000 crore and dominated by a few developed countries, an official said. The company got approval from the capital market regulator SEBI on October 29 for […]
With the healthcare sector assuming greater importance than ever in the wake of the Covid-19 pandemic, the West Bengal-based Tarsons Products Ltd - an Indian life sciences company engaged in designing, development, manufacturing and marketing of consumables, reusables and bench-top equipment - has launched a massive expansion programme and is adding two new manufacturing
Tarsons Products files initial papers with SEBI - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.